Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

XTAE:TEVA (Israel)  
₪ 36.23 (-0.52%) Dec 10
At Loss
P/B:
1.58
Market Cap:
₪ 40.83B ($ 11.02B)
Enterprise V:
₪ 111.16B ($ 30.01B)
Volume:
204.83K
Avg Vol (2M):
1.31M
Also Trade In:
Volume:
204.83K
At Loss
Avg Vol (2M):
1.31M

Business Description

Description
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset 0.17
Debt-to-Equity 2.93
Debt-to-EBITDA 1691.51
Interest Coverage 2.59
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 46.49
9-Day RSI 53.12
14-Day RSI 53.83
6-1 Month Momentum % 24.91
12-1 Month Momentum % 19.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1
Quick Ratio 0.65
Cash Ratio 0.2
Days Inventory 176.21
Days Sales Outstanding 85.01
Days Payable 94.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.6
Shareholder Yield % 14.83

Financials (Next Earnings Date:2024-02-08 Est.)

XTAE:TEVA's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Teva Pharmaceutical Industries Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₪) 56,475.123
EPS (TTM) (₪) -7.322
Beta 0
Volatility % 37.94
14-Day RSI 53.83
14-Day ATR (₪) 0.927694
20-Day SMA (₪) 35.457
12-1 Month Momentum % 19.34
52-Week Range (₪) 26.37 - 41.25
Shares Outstanding (Mil) 1,120.97

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Teva Pharmaceutical Industries Ltd Filings

Filing Date Document Date Form
No Filing Data

Teva Pharmaceutical Industries Ltd Stock Events

Event Date Price(₪)
No Event Data

Teva Pharmaceutical Industries Ltd Frequently Asked Questions

What is Teva Pharmaceutical Industries Ltd(XTAE:TEVA)'s stock price today?
The current price of XTAE:TEVA is ₪36.23. The 52 week high of XTAE:TEVA is ₪41.25 and 52 week low is ₪26.37.
When is next earnings date of Teva Pharmaceutical Industries Ltd(XTAE:TEVA)?
The next earnings date of Teva Pharmaceutical Industries Ltd(XTAE:TEVA) is 2024-02-08 Est..
Does Teva Pharmaceutical Industries Ltd(XTAE:TEVA) pay dividends? If so, how much?
Teva Pharmaceutical Industries Ltd(XTAE:TEVA) does not pay dividend.

Press Release

Subject Date
No Press Release